Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TINZAPARIN vs TISAGENLECLEUCEL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TINZAPARIN vs TISAGENLECLEUCEL: Safety Overview

Metric TINZAPARIN TISAGENLECLEUCEL
Total FAERS Reports 1,720 4,229
Deaths Reported 276 1,232
Death Rate 16.0% 29.1%
Hospitalizations 1,002 1,256
Average Patient Age 59.6 yrs 39.1 yrs
% Female Patients 48.5% 38.4%
FDA Approval Date Jul 14, 2000 N/A
Manufacturer N/A Novartis Pharmaceuticals Corporation
Route N/A INTRAVENOUS
Marketing Status Discontinued N/A